title: Is labetalol really a culprit in neonatal hypoglycaemia?
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Daskas
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Crowne
authors.forename: Julian P H
authors.initials: JP
authors.lastname: Shield
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007003:Hypoglycemia / Q000139:chemically induced*; D007231:Infant, Newborn; D007741:Labetalol / Q000009:adverse effects*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D007741:Labetalol